These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12442879)

  • 21. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
    Meltzer EO; Casale TB; Nathan RA; Thompson AK
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
    Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
    Casale TB; Andrade C; Qu R
    Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selecting the optimal oral antihistamine for patients with allergic rhinitis.
    Lehman JM; Blaiss MS
    Drugs; 2006; 66(18):2309-19. PubMed ID: 17181374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
    Milgrom H; Kittner B; Lanier R; Hampel FC
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing impairment in patients with allergic rhinitis.
    Stokes J; Fenstad E; Casale TB
    Allergy Asthma Proc; 2006; 27(1):12-6. PubMed ID: 16598987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
    Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular safety of fexofenadine HCl.
    Pratt C; Brown AM; Rampe D; Mason J; Russell T; Reynolds R; Ahlbrandt R
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():212-6. PubMed ID: 10444240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen.
    Macchia L; Caiaffa MF; Di Paola R; De Michele G; Bariletto G; Iudice A; Tursi A
    Pharmacol Res; 2001 Dec; 44(6):461-6. PubMed ID: 11735351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis.
    Harvey RP; Comer C; Sanders B; Westley R; Marsh W; Shapiro H; Wiener M
    J Allergy Clin Immunol; 1996 Jun; 97(6):1233-41. PubMed ID: 8648018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK; Gex-Collet C; Wüthrich B
    J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
    Sorkin EM; Heel RC
    Drugs; 1985 Jan; 29(1):34-56. PubMed ID: 2857636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long QT interval. Interaction of terfenadine and itraconazole].
    Rufke C; Nieber K
    Med Monatsschr Pharm; 2006 Jan; 29(1):22-4. PubMed ID: 16463550
    [No Abstract]   [Full Text] [Related]  

  • 40. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Compalati E; Baena-Cagnani R; Penagos M; Badellino H; Braido F; Gómez RM; Canonica GW; Baena-Cagnani CE
    Int Arch Allergy Immunol; 2011; 156(1):1-15. PubMed ID: 21969990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.